Cystic fibrosis: Are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease?

Radiology

Volumn 253, Issue 1, 2009, Pages 223-229

  Loeve, Martine ^a,b   Lequin, Maarten H ^b   De Bruijne, Marleen ^b,c   Hartmann, Ieneke J C ^b   Gerbrands, Krista ^a   Van Straten, Marcel ^b   Hop, Wim C J ^b   Tiddens, Harm A W M ^a,b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY PLETHYSMOGRAPH; BREATHING PATTERN; BRONCHIECTASIS; CHILD; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE QUALITY; LUNG DISEASE; LUNG FUNCTION TEST; LUNG VOLUME; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RADIATION DOSE; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METHODOLOGY; PILOT STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG DISEASES; LUNG VOLUME MEASUREMENTS; MALE; PILOT PROJECTS; RADIATION DOSAGE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 70350508400     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2532090306     Document Type: Article

References (40)

1. Levy H, Kalish LA, Huntington I, et al. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 2007;42:256-262.
2. Weiser G, Kerem E. Early intervention in CF: how to monitor the effect. Pediatr Pulmonol 2007;42:1002-1007.
3. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-951.
4. Tiddens HA, de Jong PA. Update on the application of chest computed tomography scanning to cystic fibrosis. Curr Opin Pulm Med 2006;12:433-439.
5. de Jong PA, Lindblad A, Rubin L, et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006;61:80-85.
6. de Jong PA, Nakano Y, Lequin MH, et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004;23:93-97.
7. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004;145:32-38.
8. Diederich S, Roos N, Thomas M, Peters PE. Diagnostic imaging in bronchiectases: value of CT and HRCT [in German]. Radiologe 1996;36:550-559.
9. Hansell DM. Bronchiectasis. Radiol Clin North Am 1998;36:107-128.
10. Long FR. High-resolution computed tomography of the lung in children with cystic fibrosis: technical factors. Proc Am Thorac Soc 2007;4:306-309.
11. Martinez TM, Llapur CJ, Williams TH, et al. High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis. Am J Respir Crit Care Med 2005; 172:1133-1138.
12. Bonnel AS, Song SM, Kesavarju K, et al. Quantitative air-trapping analysis in children with mild cystic fibrosis lung disease. Pediatr Pulmonol 2004;38:396-405.
13. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007;29:522-526.
14. Preston DL, Pierce DA, Shimizu Y, et al. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res 2004;162:377-389.
15. Li J, Udayasankar UK, Toth TL, Seamans J, Small WC, Kalra MK. Automatic patient centering for MDCT: effect on radiation dose. AJR Am J Roentgenol 2007;188:547-552.
16. de Jong PA, Nakano Y, Lequin MH, Tiddens HA. Dose reduction for CT in children with cystic fibrosis: is it feasible to reduce the number of images per scan? Pediatr Radiol 2006;36:50-53.
17. Paterson A, Frush DP. Dose reduction in paediatric MDCT: general principles. Clin Radiol 2007;62:507-517.
18. Robinson TE. Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 2007;4:310-315.
19. Bankier AA, Schaefer-Prokop C, De Maertelaer V, et al. Air trapping: comparison of standard-dose and simulated low-dose thin-section CT techniques. Radiology 2007;242:898-906.
20. About MIPAV: medical image processing, analysis, and visualization. Center for Information Technology: National Institutes of Health. http://mipav.cit.nih.gov/. Updated March 14, 2007. Accessed September 14, 2007.
21. McAuliffe M, Lalonde F, McGarry D, Gandler W, Csaky K, Trus B. Medical image processing, analysis and visualization in clinical research. In: Proceedings of 14th IEEE symposium on computer-based medical systems (CBMS 2001). Los Alamitos, Calif: IEEE, 2001; 381-386.
22. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents: methods, reference values. Basel, Switzerland: Karger, 1987.
23. European Commission. European guidelines on quality criteria for computed tomography. Report EUR 16262. Brussels, Belgium: European Commission, 1999.
24. Jones D, Shrimpton P. Survey of CT practice in the UK: normalised organ doses for x-ray computed tomography using Monte Carlo techniques. Harwell, England: National Radiological Protection Board, 1991.
25. Khursheed A, Hillier MC, Shrimpton PC, Wall BF. Influence of patient age on normalized effective doses calculated for CT examinations. Br J Radiol 2002;75:819-830.
26. Long FR, Williams RS, Adler BH, Castile RG. Comparison of quiet breathing and controlled ventilation in the high-resolution CT assessment of airway disease in infants with cystic fibrosis. Pediatr Radiol 2005;35:1075-1080.
27. Loeve M, van Hal PTW, Robinson P, et al. CT scans from CF patients screened for lung transplantation: the severe advanced lung disease (SALD) CT scoring system and correlation with survival - preliminary results. Presented at the North American Cystic Fibrosis Conference, Anaheim, Calif, October 4-6, 2007.
28. Tiddens HA, Koopman LP, Lambert RK, et al. Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis lungs. Eur Respir J 2000;15:735-742.
29. Hays SR, Ferrando RE, Carter R, Wong HH, Woodruff PG. Structural changes to airway smooth muscle in cystic fibrosis. Thorax 2005;60:226-228.
30. Rosenthal M. Annual assessment spirometry, plethysmography, and gas transfer in cystic fibrosis: do they predict death or transplantation. Pediatr Pulmonol 2008;43: 945-952.
31. Blair E, Hickam JB. The effect of change in body position on lung volume and intrapulmonary gas mixing in normal subjects. J Clin Invest 1955;34:383-389.
32. Kohz P, Stabler A, Beinert T, et al. Reproducibility of quantitative, spirometrically controlled CT. Radiology 1995;197:539-542.
33. Brown RH, Mitzner W, Wagner E, Permutt S, Togias A. Airway distension with lung inflation measured by HRCT. Acad Radiol 2003;10:1097-1103.
34. Lee KN, Yoon SK, Choi SJ, Goo JM, Nam KJ. Cystic lung disease: a comparison of cystic size, as seen on expiratory and inspiratory HRCT scans. Korean J Radiol 2000;1: 84-90.
35. Goris ML, Zhu HJ, Blankenberg F, Chan F, Robinson TE. An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 2003;123:1655-1663.
36. Brody AS, Frush DP, Huda W, Brent RL. Radiation risk to children from computed tomography. Pediatrics 2007;120:677-682.
37. Tiddens HA. Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Paediatr Respir Rev 2006;7:202-208.
38. de Jong PA, Mayo JR, Golmohammadi K, et al. Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med 2006;173: 199-203.
39. de Gonzalez AB, Kim KP, Samet JM. Radiation-induced cancer risk from annual computed tomography for patients with cystic fibrosis. Am J Respir Crit Care Med 2007;176: 970-973.
40. Altes TA, Eichinger M, Puderbach M. Magnetic resonance imaging of the lung in cystic fibrosis. Proc Am Thorac Soc 2007;4:321-327.